149 related articles for article (PubMed ID: 9564029)
1. Crystal structure of human uroporphyrinogen decarboxylase.
Whitby FG; Phillips JD; Kushner JP; Hill CP
EMBO J; 1998 May; 17(9):2463-71. PubMed ID: 9564029
[TBL] [Abstract][Full Text] [Related]
2. Characterization and crystallization of human uroporphyrinogen decarboxylase.
Phillips JD; Whitby FG; Kushner JP; Hill CP
Protein Sci; 1997 Jun; 6(6):1343-6. PubMed ID: 9194196
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase.
Phillips JD; Whitby FG; Kushner JP; Hill CP
EMBO J; 2003 Dec; 22(23):6225-33. PubMed ID: 14633982
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis.
Fan J; Liu Q; Hao Q; Teng M; Niu L
J Bacteriol; 2007 May; 189(9):3573-80. PubMed ID: 17122346
[TBL] [Abstract][Full Text] [Related]
5. Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen.
Phillips JD; Warby CA; Whitby FG; Kushner JP; Hill CP
J Mol Biol; 2009 Jun; 389(2):306-14. PubMed ID: 19362562
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure and substrate binding modeling of the uroporphyrinogen-III decarboxylase from Nicotiana tabacum. Implications for the catalytic mechanism.
Martins BM; Grimm B; Mock HP; Huber R; Messerschmidt A
J Biol Chem; 2001 Nov; 276(47):44108-16. PubMed ID: 11524417
[TBL] [Abstract][Full Text] [Related]
7. Human uroporphyrinogen III synthase: NMR-based mapping of the active site.
Cunha L; Kuti M; Bishop DF; Mezei M; Zeng L; Zhou MM; Desnick RJ
Proteins; 2008 May; 71(2):855-73. PubMed ID: 18004775
[TBL] [Abstract][Full Text] [Related]
8. Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
Warby CA; Phillips JD; Bergonia HA; Whitby FG; Hill CP; Kushner JP
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):40-5. PubMed ID: 19656450
[TBL] [Abstract][Full Text] [Related]
9. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
Garey JR; Harrison LM; Franklin KF; Metcalf KM; Radisky ES; Kushner JP
J Clin Invest; 1990 Nov; 86(5):1416-22. PubMed ID: 2243121
[TBL] [Abstract][Full Text] [Related]
10. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Phillips JD; Bergonia HA; Reilly CA; Franklin MR; Kushner JP
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5079-84. PubMed ID: 17360334
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of human uroporphyrinogen decarboxylase.
Wyckoff EE; Phillips JD; Sowa AM; Franklin MR; Kushner JP
Biochim Biophys Acta; 1996 Dec; 1298(2):294-304. PubMed ID: 8980654
[TBL] [Abstract][Full Text] [Related]
12. Density-functional study of mechanisms for the cofactor-free decarboxylation performed by uroporphyrinogen III decarboxylase.
Silva PJ; Ramos MJ
J Phys Chem B; 2005 Sep; 109(38):18195-200. PubMed ID: 16853337
[TBL] [Abstract][Full Text] [Related]
13. Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP).
Phillips JD; Whitby FG; Stadtmueller BM; Edwards CQ; Hill CP; Kushner JP
Transl Res; 2007 Feb; 149(2):85-91. PubMed ID: 17240319
[TBL] [Abstract][Full Text] [Related]
14. A tale of two acids: when arginine is a more appropriate acid than H3O+.
Silva PJ; Schulz C; Jahn D; Jahn M; Ramos MJ
J Phys Chem B; 2010 Jul; 114(27):8994-9001. PubMed ID: 20553007
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
Phillips JD; Parker TL; Schubert HL; Whitby FG; Hill CP; Kushner JP
Blood; 2001 Dec; 98(12):3179-85. PubMed ID: 11719352
[TBL] [Abstract][Full Text] [Related]
16. Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping.
Wu C; Xu W; Kozak CA; Desnick RJ
Mamm Genome; 1996 May; 7(5):349-52. PubMed ID: 8661721
[TBL] [Abstract][Full Text] [Related]
17. Localisation of Plasmodium falciparum uroporphyrinogen III decarboxylase of the heme-biosynthetic pathway in the apicoplast and characterisation of its catalytic properties.
Nagaraj VA; Arumugam R; Chandra NR; Prasad D; Rangarajan PN; Padmanaban G
Int J Parasitol; 2009 Apr; 39(5):559-68. PubMed ID: 19041871
[TBL] [Abstract][Full Text] [Related]
18. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human uroporphyrinogen III synthase.
Mathews MA; Schubert HL; Whitby FG; Alexander KJ; Schadick K; Bergonia HA; Phillips JD; Hill CP
EMBO J; 2001 Nov; 20(21):5832-9. PubMed ID: 11689424
[TBL] [Abstract][Full Text] [Related]
20. A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase.
Eads JC; Ozturk D; Wexler TB; Grubmeyer C; Sacchettini JC
Structure; 1997 Jan; 5(1):47-58. PubMed ID: 9016724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
